Mei-Ling Siu–Caldera

594 total citations
20 papers, 482 citations indexed

About

Mei-Ling Siu–Caldera is a scholar working on Pathology and Forensic Medicine, Genetics and Molecular Biology. According to data from OpenAlex, Mei-Ling Siu–Caldera has authored 20 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pathology and Forensic Medicine, 7 papers in Genetics and 6 papers in Molecular Biology. Recurrent topics in Mei-Ling Siu–Caldera's work include Vitamin D Research Studies (17 papers), Estrogen and related hormone effects (7 papers) and Retinoids in leukemia and cellular processes (4 papers). Mei-Ling Siu–Caldera is often cited by papers focused on Vitamin D Research Studies (17 papers), Estrogen and related hormone effects (7 papers) and Retinoids in leukemia and cellular processes (4 papers). Mei-Ling Siu–Caldera collaborates with scholars based in United States, Japan and Switzerland. Mei-Ling Siu–Caldera's co-authors include Milan R. Uskoković, G. Satyanarayana Reddy, Paul Vouros, G.S. Reddy, Andrew Weiskopf, D.Sunita Rao, Anthony W. Norman, W. H. OKAMURA, Meinrad Peterlik and Martin Bischof and has published in prestigious journals such as FEBS Letters, Endocrinology and Journal of Medicinal Chemistry.

In The Last Decade

Mei-Ling Siu–Caldera

20 papers receiving 465 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mei-Ling Siu–Caldera United States	14	378	170	126	108	107	20	482
Anne‐Marie Kissmeyer Denmark	12	269 0.7×	104 0.6×	143 1.1×	68 0.6×	48 0.4×	19	512
T E Tavela United States	9	179 0.5×	123 0.7×	264 2.1×	75 0.7×	85 0.8×	10	513
Judith Lund United States	7	456 1.2×	148 0.9×	94 0.7×	123 1.1×	146 1.4×	8	647
Andrew J. Annalora United States	12	169 0.4×	85 0.5×	176 1.4×	40 0.4×	163 1.5×	20	485
Michiyasu Ishizawa Japan	12	174 0.5×	89 0.5×	159 1.3×	57 0.5×	49 0.5×	25	468
Manabu Matsunawa Japan	9	150 0.4×	65 0.4×	135 1.1×	57 0.5×	35 0.3×	22	401
B. Pelc United Kingdom	8	152 0.4×	59 0.3×	78 0.6×	37 0.3×	71 0.7×	38	306
J M Dupret France	10	109 0.3×	87 0.5×	327 2.6×	40 0.4×	33 0.3×	14	511
Craig L. Driver United States	8	142 0.4×	215 1.3×	151 1.2×	25 0.2×	64 0.6×	9	408
Nancy Lowe United States	11	277 0.7×	16 0.1×	217 1.7×	55 0.5×	48 0.4×	14	667

Countries citing papers authored by Mei-Ling Siu–Caldera

Since Specialization

Citations

This map shows the geographic impact of Mei-Ling Siu–Caldera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mei-Ling Siu–Caldera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mei-Ling Siu–Caldera more than expected).

Fields of papers citing papers by Mei-Ling Siu–Caldera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mei-Ling Siu–Caldera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mei-Ling Siu–Caldera. The network helps show where Mei-Ling Siu–Caldera may publish in the future.

Co-authorship network of co-authors of Mei-Ling Siu–Caldera

This figure shows the co-authorship network connecting the top 25 collaborators of Mei-Ling Siu–Caldera. A scholar is included among the top collaborators of Mei-Ling Siu–Caldera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mei-Ling Siu–Caldera. Mei-Ling Siu–Caldera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Swami, Srilatha, et al.. (2003). A Low-Calcemic Vitamin D Analog (Ro 25-4020) Inhibits the Growth of LNCaP Human Prostate Cancer Cells with Increased Potency by Producing an Active 24-Oxo Metabolite (Ro 29-9970). Recent results in cancer research. 164. 349–352. 4 indexed citations

Rao, D.Sunita, Mei-Ling Siu–Caldera, Lynn Gennaro, et al.. (2002). Metabolism of 2-Methyl Analogs of 1α,25-Dihydroxyvitamin D<sub>3</sub> in Rat Osteosarcoma Cells (UMR 106). Biological and Pharmaceutical Bulletin. 25(7). 845–852. 4 indexed citations

Nakagawa, Kimie, Keiichi Ozono, Mei-Ling Siu–Caldera, et al.. (2001). Differential activities of 1α,25-dihydroxy-16-ene-vitamin D3 analogs and their 3-epimers on human promyelocytic leukemia (HL-60) cell differentiation and apoptosis. Steroids. 66(3-5). 327–337. 37 indexed citations

Uskoković, Milan R., Anthony W. Norman, Percy S. Manchand, et al.. (2001). Highly active analogs of 1α,25-dihydroxyvitamin D3 that resist metabolism through C-24 oxidation and C-3 epimerization pathways. Steroids. 66(3-5). 463–471. 50 indexed citations

Reddy, G. Satyanarayana, D.Sunita Rao, Mei-Ling Siu–Caldera, et al.. (2000). 1α,25-Dihydroxy-16-ene-23-yne-vitamin D3 and 1α,25-Dihydroxy-16-ene-23-yne-20-epi-vitaminD3: Analogs of 1α,25-Dihydroxyvitamin D3 That Resist Metabolism through the C-24 Oxidation Pathway Are Metabolized through the C-3 Epimerization Pathway. Archives of Biochemistry and Biophysics. 383(2). 197–205. 21 indexed citations

Posner, Gary H., Kenneth Crawford, Mei-Ling Siu–Caldera, et al.. (2000). Conceptually New 20-epi-22-Oxa Sulfone Analogues of the Hormone 1α,25-Dihydroxyvitamin D₃: Synthesis and Biological Evaluation. Journal of Medicinal Chemistry. 43(19). 3581–3586. 20 indexed citations

Weinstein, Edward A., D.Sunita Rao, Mei-Ling Siu–Caldera, et al.. (1999). Isolation and identification of 1α-hydroxy-24-oxovitamin D 3 and 1α,23-dihydroxy-24-oxovitamin D 3. Biochemical Pharmacology. 58(12). 1965–1973. 8 indexed citations

Campbell, Moray J., Mark T. Drayson, Jennifer N. Durham, et al.. (1999). Metabolism of 1α,25(OH)2D3 and its 20-epi analog integrates clonal expansion, maturation and apoptosis during HL-60 cell differentiation. Molecular and Cellular Endocrinology. 149(1-2). 169–183. 14 indexed citations

Rao, D.Sunita, Mei-Ling Siu–Caldera, Milan R. Uskoković, Ronald L. Horst, & G. Satyanarayana Reddy. (1999). Physiological Significance of C-28 Hydroxylation in the Metabolism of 1α,25-Dihydroxyvitamin D2. Archives of Biochemistry and Biophysics. 368(2). 319–328. 13 indexed citations

10.

Siu–Caldera, Mei-Ling, Andrew Weiskopf, Paul Vouros, et al.. (1999). 1α,25‐Dihydroxy‐3‐epi‐vitamin D₃: In vivo metabolite of 1α,25‐dihydroxyvitamin D₃ in rats. FEBS Letters. 448(2-3). 278–282. 44 indexed citations

11.

Rao, D.Sunita, R. Dayal, Mei-Ling Siu–Caldera, et al.. (1999). Isolation and identification of 4,25-dihydroxyvitamin D2: a novel A-ring hydroxylated metabolite of vitamin D2. The Journal of Steroid Biochemistry and Molecular Biology. 71(1-2). 63–70. 8 indexed citations

12.

Siu–Caldera, Mei-Ling, Andrew Weiskopf, Paul Vouros, et al.. (1999). Production of 1α,25-Dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed. Bone. 24(5). 457–463. 42 indexed citations

13.

Yang, Wen, Peter A. Friedman, Rajiv Kumar, et al.. (1999). Expression of 25(OH)D₃24-hydroxylase in distal nephron: coordinate regulation by 1,25(OH)₂D₃and cAMP or PTH. American Journal of Physiology-Endocrinology and Metabolism. 276(4). E793–E805. 29 indexed citations

14.

Bischof, Martin, Mei-Ling Siu–Caldera, Andrew Weiskopf, et al.. (1998). Differentiation-Related Pathways of 1α,25-Dihydroxycholecalciferol Metabolism in Human Colon Adenocarcinoma-Derived Caco-2 Cells: Production of 1α,25-Dihydroxy-3epi-cholecalciferol. Experimental Cell Research. 241(1). 194–201. 64 indexed citations

15.

Siu–Caldera, Mei-Ling, Jeffrey W. Clark, Sara Peleg, et al.. (1996). 1α,25-dihydroxy-24-oxo-16-ene vitamin D3, a metabolite of a synthetic vitamin D3 analog, 1α,25-dihydroxy-16-ene vitamin D3, is equipotent to its parent in modulating growth and differentiation of human leukemic cells. The Journal of Steroid Biochemistry and Molecular Biology. 59(5-6). 405–412. 28 indexed citations

16.

Rao, L.G., May Kung Sutherland, G.S. Reddy, et al.. (1996). Effects of 1α,25-dihydroxy-16ene, 23yne-vitamin D3 on osteoblastic function in human osteosarcoma SaOS-2 cells: differentiation-stage dependence and modulation by 17-β estradiol. Bone. 19(6). 621–627. 23 indexed citations

17.

Yeung, Bernice, Paul Vouros, Mei-Ling Siu–Caldera, & G. Satyanarayana Reddy. (1995). Characterization of the metabolic pathway of 1,25-dihydroxy-16-ene vitamin D3 in rat kidney by on-line high performance liquid chromatography-electrospray tandem mass spectrometry. Biochemical Pharmacology. 49(8). 1099–1110. 23 indexed citations

18.

Siu–Caldera, Mei-Ling, et al.. (1995). Human osteoblasts in culture metabolize both 1 alpha, 25-dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones.. Endocrinology. 136(10). 4195–4203. 28 indexed citations

19.

Siu–Caldera, Mei-Ling. (1995). Human osteoblasts in culture metabolize both 1 alpha, 25- dihydroxyvitamin D3 and its precursor 25-hydroxyvitamin D3 into their respective lactones. Endocrinology. 136(10). 4195–4203. 10 indexed citations

20.

O’Brien, Kimberly, Lindsay H. Allen, Paula A. Quatromoni, et al.. (1993). High Fiber Diets Slow Bone Turnover in Young Men but Have No Effect on Efficiency of Intestinal Calcium Absorption. Journal of Nutrition. 123(12). 2122–2128. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact